6360abefb0d6371309cc9857

Full Text

Clinical Study

Link between Chronic Kidney Disease (CKD) and Known Risk Factors: A Hospital-based Study in Pakistan


Abstract
Background and objective: chronic kidney disease (ckd) is a progressive disease which is not curable with high morbidity and mortality rate. Despite the harmful consequences of ckd, few studies have been conducted in pakistan regarding ckd which are also outdated. So, the objective of the study was to determine the socio-demographic and preventable clinical risk factors associated with ckd.

Methods: patients visiting the outdoor department of nephrology or those admitted in ward between feb-nov 2019 were selected for the study. A questionnaire including demographic information and risk factors for ckd was filled after informed consent. Data was analyzed on spss software. Main outcome measures: risk factors including hypertension, diabetes, positive history of ckd and kidney stone were found to be associated with ckd development.

Results: a total of 200 patients participated in the study in which 131 (65.5%) were female. Risk factor data revealed older age (p-value 0.02), hypertension (p-value 0.02), diabetes (p-value 0.03) and positive family history of ckd (p-value 0.01) to be associated with disease development. Logistic regression revealed that old age increases the odds of ckd by 3 times followed by positive family history of ckd (or: 2.2) and history of renal stone (or: 1.8).

Conclusion: numerous risk factors are associated with the progression of ckd. Our findings are the first to provide a quantitative estimate of the risk posed by different factors on ckd in pakistan. Our findings emphasize the pressing need for designing early detection and treatment plans for ckd followed by its prevention policies in pakistan.

Key words: chronic kidney disease; diabetes; hypertension; kidney disease; risk factors

Figure 1. Age distribution of study participants

Data related to the ckd of the patients and history of hypertension, dm and cardiovascular diseases among the patients and adjusted ratio of the factors related to ckd has been shown below.

(table 1) shows information related to various risk factors of ckd. Majority of the patients in the study were females. Almost all the risk factors were found in the patients reporting to the renal department with the majority of the patients already suffering from diabetes and hypertension.

Table 1. Frequency of risk factors in study participants

Variable

Frequency

N (%)

Sex

 

Female

131 (65.5)

Male

69 (34.5)

History of htn

 

No

49(24.5)

Yes

151(75.5)

History of dm

 

No

23(11.5)

Yes

177(88.5)

History of cigarette smoking

 

No

125(62.5)

Yes

75(37.5)

History of nsaids

 

No

30(15)

Yes

170(85)

History of ckd in family

 

No

90(45)

Yes

110(55)

History of renal stone

 

No

179(89.5)

Yes

21(10.5)

Htn: hypertension, dm: diabetes mellitus, nsaids: non-steroidal anti-inflammatory drugs, ckd: chronic kidney disease

To confirm if the demographic variables and known environmental factors actually played a significant role in the development of chronic kidney disease (ckd), chisquare test was performed andp < 0.05 was considered significant (table 2). Results revealed that factors including age between 39-48, history of hypertension, dm, use of drugs and positive history of ckd in family were statistically significant for their role in the development of ckd (table 2).

Table 2. Risk factors for chronic kidney disease

 

Variables

Frequency of patients

(n)

 

P-value

Age

 

 

18-28

47

0.07

29-38

24

0.08

39-48

49

0.01

49-58

66

0.28

59-68

8

0.19

>68

6

0.02

History of htn

 

 

No

49

0.02

Yes

151

History of dm

 

 

No

23

0.03

Yes

177

History of cigarette smoking

 

 

No

125

0.75

Yes

75

History of nsaids

 

 

No

30

0.01

Yes

170

History of ckd in family

 

 

No

90

0.01

Yes

110

History of renal stone

 

 

No

179

0.79

Yes

21

Htn: hypertension, dm: diabetes mellitus, nsaids: non-steroidal anti-inflammatory drugs, ckd: chronic kidney disease

These factors were further evaluated through logistic regression for calculation of odds ratio (table 3). Old age showed the highest odds of increasing ckd by 3 times followed by positive family history of ckd (or: 2.2) and history of renal stone (or: 1.8).

Table 3. Logistic regression for risk factors of ckd

Variables

Aor (95% ci)

Age

 

18-28

1.46(1.05,2.03)

29-38

1.50(0.95,2.36)

39-48

2.40(1.59,3.65)

49-58

0.77(0.49,1.23)

59-68

1.40(0.85,2.32)

>68

3.16(1.36,7.35)

History of htn

1.26(0.97,1.64)

History of dm

0.70(0.51,0.96)

History of cigarette smoking

1.05(0.76,1.45)

History of nsaids

0.48(0.37,0.61)

History of ckd in family

2.22(1.65,2.98)

History of renal stone

1.76(1.34,2.31)

Htn: hypertension, dm: diabetes mellitus, nsaids: non-steroidal anti-inflammatory drugs, ckd: chronic kidney disease 

 

1.     Discussion

Chronic kidney disease (ckd) is a progressive disease which is not curable with high morbidity and mortality rate10. Our study is the first to quantify the risk posed by socio-demographic and preventable clinical risk factors associated with ckd.

Age is documented as an independent risk factor for the development of renal disease11 and our findings of high prevalence of ckd in older people were consistent with previous studies9,12. Hypertension and diabetes are considered strong predictors for kidney dysfunction progression13,14. We found strong association of htn and dm with ckd in our study which is consistent with previous studies done in other countries15,16. Our results are also consistent with findings from a study done by jessani et al., in 20149. Another important risk factor was positive family history of ckd. We found that the odds of ckd increase 2.2 times if the disease is already present in the family. Previous studies have also demonstrated positive family history as predictors of ckd17. Okwuonu et al., 2017 found that the odds of ckd increase by 4.5 times in these cases18. This is the first study from pakistan that has provided a quantitative estimate of the risk posed by positive family history on the development of ckd.

Kidney stones have long been associated with elevated risk for chronic renal disease. Our study shows that the risk of ckd increases by almost 1.8 times in patients with a positive history of kidney stones. A study from taiwan19 also found an association between kidney stones and poor ckd prognosis. Two recent studies have also highlighted the strong association between kidney stone and ckd20,21. Hence, it can be said that htn, dm, positive history of ckd and kidney stones are among the major causes of ckd in pakistan.

Smoking is also associated with cdk. Our results of 1.05 odds ratio are comparable with an american study done in 2018 which also showed odds ratio of 1.02 for ckd progression22. However, detailed studies need to be done in this area for comprehensive results.

The present study had its limitations that are worth mentioning. Firstly, serum creatinine level was used for the diagnosis of ckd in which albuminuria was not taken into consideration. Diet, total muscle mass, and comorbidities can affect creatinine levels which can in turn lead to a misclassification of the outcome. However, other studies have also used single measurement for epidemiological research23. Secondly; the study was conducted in lahore so findings can be different in other areas of pakistan. However, healthcare services provided in other areas are not better than lahore. We recommend comprehensive studies to be conducted for exact identification of the burden posed by ckd and controlling its risk factors in different areas of the country for disease prevention. Only then, effective policies to control ckd can be formulated.

2.     Conclusion
Numerous risk factors are associated with the progression of ckd. Our findings are the first to provide a quantitative estimate of the risk posed by different factors on ckd in pakistan. Our findings emphasize the pressing need for designing early detection and treatment plans for ckd followed by its prevention policies in pakistan, and other developing countries with high ckd burden.

3.     Acknowledgement
We would like to express our heartfelt gratitude and appreciation to ayesha bashir hospital pakistan for all the support the center provided during the course of study and special thanks to dr. Ijaz bashir for his expertise and assistance throughout all aspects of the study.

4.     Conflicts of interest
None declared

5.     Financial support & sponsorship
None received

References

1.      National kidney foundation. K-doqi clinical practice guidelines for chronic kidney disease: evaluation, classification and stratification. Am j kidney dis 2002;39(1):s1-s266.

2.      Hasan m, sutradhar i, gupta, rd, sarker m. Prevalence of chronic kidney disease in south asia: a systematic review. Bmc nephrol 2018;19:291.

3.    Yaqub s, kashif w, raza mq, et al. General practitioners' knowledge and approach to chronic kidney disease in karachi, pakistan. Indian j nephrol 2013;23(3):184-90

4.      Gbd 2015 mortality and causes of death collaborators. Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980-2015: a systematic analysis for the global burden of disease study 2015. Lancet 2016;388:1459-1544.

5.      Garcia-garcia g, jha v. World kidney day steering committee. Ckd in disadvantaged populations. Kidney int 2015;87:251-253.

6.     Alam a, amanullah f, baig-ansari n, lotia-farrukh i, khan fs. Prevalence and risk factors of kidney disease in urban karachi: baseline findings from a community cohort study. Bmc res notes 2014;7(1):179.

7.     Imran s, sheikh a, saeed z, et al. Burden of chronic kidney disease in an urban city of pakistan, a cross-sectional study. J pak med assoc 2015;65(4):366.

8. Jafar th, schmid ch, levey as. Serum creatinine as marker of kidney function in south asians: a study of reduced gfr in adults in pakistan. J am soc nephrol 2005;16(5):1413-1419.

9.      Jessani s, bux r, jafar th. Prevalence, determinants, and management of chronic kidney disease in karachi, pakistan - a community based cross-sectional study. Bmc nephrol 2014;15:90.

10.   Webster ac, nagler ev, morton rl, masson p. Chronic kidney disease. Lancet 2017;389(10075):1238-1252.

11.   Neugarten j, gallo g, silbiger s, kasiske b. Glomerulosclerosis in aging humans is not influenced by gender. Am j kidney dis 1999;34(5):884-888.

12.   Yamagata k, ishida k, sairenchi t, et al. Risk factors for chronic kidney disease in a community-based population: a 10-year follow up study. Kidney int 2007;71(2):159-166.

13.   Ruggenenti p, schieppati a, remuzzi g. Progression, remission, regression of chronic renal diseases. Lancet 2001;35(9268):1601-1608.

14.   Iseki k, oshiro s, tozawa m, ikemiya y, fukiyama k, takishita s. Prevalence and correlates of diabetes mellitus in a screened cohort in okinawa, japan. Hypertens res 2002;25(2):185-190.

15.   Tannor ek, sarfo fs, mobula lm, sarfo-kantanka o, adu-gyamfi r, plange-rhule j. Prevalence and predictors of chronic kidney disease among ghanaian patients with hypertension and diabetes mellitus: a multicenter cross-sectional study. J clin hypertens (greenwich). 2019;21(10):1542-1550.

16. Damtie s, biadgo b, baynes hw, et al. Chronic kidney disease and associated risk factors assessment among diabetes mellitus patients at a tertiary hospital, northwest ethiopia. Ethiop j health sci 2018;28(6):691-700.

17.   Nalado a, abdu a, adanu b, et al. Prevalence of chronic kidney disease markers in kumbotso rural northen nigeria. Afr j med sci 2016;45(1):61-65.

18.   Okwuonu cg, chukwuonye ii, adejumo oa, agaba ei, ojogwu li. Prevalence of chronic kidney disease and its risk factors among adults in a semi-urban community of south-east nigeria. Niger postgrad med j 2017;24(2):81-87.

19.   Li cc, chien tm, wu wj, huang cn, chou yh. Uric acid stones increase the risk of chronic kidney disease. Urolithiasis 2018;46:543-547.

20.   Jaime u. Chronic kidney disease and kidney stones. Curr opin nephrol hypertens 2020;29(2):237-242.

21.  Dhondup t, kittanamongkolchai w, vaughan le, et al. Risk of esrd and mortality in kidney and bladder stone formers. Am j kidney dis 2018;72(6):790-797.

22.   Bundy jd, bazzano la, xie d, et al. Self-reported tobacco, alcohol, and illicit drug use and progression of chronic kidney disease. Clin j am soc   nephrol 2018;13(7):993-1001.

23.   Coresh j, selvin e, stevens la, et al. Prevalence of chronic kidney disease in the united states. Jama 2007;298(17):2038-2047